Evaluate the @-week efficacy and safety of desvenlafaxine at the recommended dose of @ mg/d in perimenopausal and postmenopausal women with major depressive disorder ( MDD ) based on the Diagnostic and Statistical Manual of Mental Disorders , Fourth Edition , Text Revision .